Association between the CCR2-Val64Ile polymorphism and susceptibility to HIV-1 infection: A meta-analysis

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 181-186

  Ding, Dong Lin ^a   Liu, Si Jie ^a   Zhu, Huan Zhang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CCR2 Val64Ile; Human immune deficiency virus type 1; Meta analysis; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR2;

ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; INFANT; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; META ANALYSIS; SAMPLE SIZE;

GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; RECEPTORS, CCR2; RISK ASSESSMENT; RISK FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78651384350     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.400     Document Type: Article

References (32)

1. Singh P, Kaur G, Sharma G and Mehra NK: Immunogenetic basis of HIV-1 infection, transmission and disease progression. Vaccine 26: 2966-2980, 2008.
2. Dean M, Carrington M, Winkler C, et al: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 273: 1856-1862, 1996.
3. Fauci AS: Resistance to HIV-1 infection: it's in the genes. Nat Med 2: 966-967, 1996. (Pubitemid 26306827)
4. Paxton WA and Kang S: Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 10: 187-194, 1998.
5. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Setphan KT, Craig FE, O'Connell P, Tryon V, Clark RA, Dolan MJ and Ahuja SK: Genealogy of the CCR5 locus and chemokine system genevariants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786-793, 1998. (Pubitemid 28331019)
6. Michael NL: Host genetic influences on HIV-1 pathogenesis. Curr Opin Immunol 11: 466-474, 1999.
7. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH and Murphy PM: Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14: 2671-2678, 2000. (Pubitemid 32118720)
8. Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE and Spector SA: Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 188: 1461-1472, 2003. (Pubitemid 37523931)
9. Daugherty BL and Springer MS: The β-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMBRK3) cluster within 285 kb on human chromosome3p21. Genomics 41: 294-297, 1997.
10. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusin cofactors. Cell 85: 1149-1158, 1996.
11. Smith MW, Dean M, Carrington M, et al: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277: 959-965, 1997.
12. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU and Ho DD: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4: 350-353, 1998. (Pubitemid 28144097)
13. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, et al: Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS 17: 1631-1638, 2003.
14. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM and Martinez AC: Chemokine control of HIV-1 infection. Nature 400: 723, 1999.
15. Ioannidis JP, Rosenberg PS, Goedert JJ, et al: Effects of CCR5-delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 135: 782-795, 2001.
16. Louisirirotchanakul S, Liu H, Roongpisuthipong A, Nakayama EE, Takebe Y, Shioda T and Wasi C: Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 641 homozygosity with HIV-1-negative status. J Acquir Immune Defic Syndr 29: 314-315, 2002. (Pubitemid 34208542)
17. Petersen DC, Laten A, Zeier MD, Grimwood A, Rensburg EJ and Hayes VM: Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay. Hum Mutat 20: 253-259, 2002.
18. De Pinho Lott Carvalhaes FA, Lemos Cardoso G, Rosário Vallinoto AC, et al: Frequencies of CCR5-Δ32, CCR2-64I and SDF1-3′A mutations in human immunodeficiency virus (HIV) seropositive subjects and seronegative individuals from the state of Para in Brazilian Amazonia. Genet Mol Biol 28: 665-669, 2005.
19. Shrestha S, Strathdee SA, Galai N, et al: Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis 193: 16-26, 2006. (Pubitemid 43033317)
20. Wichukchinda N, Nakayama EE, Rojanawiwat A, et al: Effects of CCR2 and CCR5 polymorphisms on HIV-1 infection in Thai females. J Acquir Immune Defic Syndr 47: 293-297, 2008. (Pubitemid 351619413)
21. Tan XH, Zhang JY, Di CH, et al: Distribution of CCR5-A32, CCR5 m303A, CCR2-64I and SDF1-3A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China. Infect Genet Evol 10: 268-272, 2010.
22. Roman F, Franck N, Burgy C, et al: Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in Luxembourg. HIV Clin Trials 3: 195-201, 2002. (Pubitemid 34704867)
23. Wang FS, Hong WG, Cao Y, et al: Population survey of CCR5Δ32, CCR5m303, CCR2b64I, and SDF1 3′A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups. J Acquir Immune Defic Syndr 32: 124-130, 2003.
24. Philpott S, Burger H, Tarwater PM, et al: CCR2 genotype and disease progression in a treated population of HIV type 1-infected women. Clin Infect Dis 39: 861-865, 2004. (Pubitemid 39244303)
25. Paz-y-mino C, Morillo SA, Celi AP, et al: CCR5Δ32, CCR2-64I, and SDF1-3′A polymorphisms related to resistance to HIV-1 infection and disease in the Ecuadorian population. Human Biology 77: 521-526, 2005
26. Brouwer KC, Yang CF, Parekh S, et al: Effect of CCR2 chemokine receptor polymorphism on HIV type 1 mother-to-child transmission and child survival in Western Kenya. AIDS Res Hum Retrov 21: 358-362, 2005. (Pubitemid 40800451)
27. Suresh P, Wanchu A, Kaur Sachdeva R and Bhatnagar A: Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J Clin Immunol 26: 476-484, 2006. (Pubitemid 44440181)
28. Kaur G, Singh P, Kumar N, Rapthap CC, Sharma G, Vajpayee M, Wig N, Sharma SK and Mehra NK: Distribution of CCR2 polymorphism in HIV-1-infected and healthy subjects in North India. Int J Immunogenet 34: 153-156, 2007. (Pubitemid 46763547)
29. Parczewski M, Leszczyszyn-Pynka M, Kaczmarczyk M, Adler G, Binczak-Kuleta A, Loniewska B, Boroñ-Kaczmarska A and Ciechanowicz A: Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection. J Appl Genet 50: 159-166, 2009.
30. Cochran WG: The combination of estimates from different experiments. Biometrics 10: 29, 1954.
31. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
32. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.